EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
mRNA Platforms as Diagnostics and Therapeutics for Human Infertility Treatments
Associate Professor, Department of Biology, Khalifa University
Junaid Kashir is an Associate Professor in the Department of Biology at Khalifa University and
has previously chaired multiple researchadministrative committees He has been heavily
involved in multiple programs for training graduate clinical embryology students Dr Kashirs
research aims to develop therapeuticdiagnostic interventions to treat infertility and understand
embryology
Articles
A BITTER PILL: Exploring the Realm of Drug Counterfeiting
In the total number of counterfeit pills and other medications seized by Interpols Pangea pharmaceutical investigation team reached milliona drastic increase over the million seized by the same team in In May alone a single Interpol operation lead to the seizure of million counterfeit medicationsa haul of fraudulent g
Research Insights
Knowledge integration using product R&D outsourcing in biotechnology
Abstract We build on systems integration literature to explain how and why knowledge integration of nonmodular products is based on a strategic choice between internalizing and outsourcing core RD The underresearched choice of outsourcing core RD on an ongoing basis appears to face risks of higher transactions costs and loss of control We illumina
Case Studies
Ambient Stable Biologics - Stable Aqueous Erythropoietin
Challenge Erythropoietin EPO is known to aggregate under heat stress which prevents storage of liquid compositions at ambient temperature The key challenge of this study was to demonstrate that the application of the ArestatT tools can reduce significantly aggregation of EPO at an elevated temperature compared with a marketed liquid formulation
Techno Trends
Millipore\'s innovative MobiusT Disposable TFF Assemblies
Millipore Corporation has announced the availability of new Mobius disposable TFF assemblies which offer flexible selfcontained solutions that reduce validation efforts increase process speed and mitigate risks Mobius disposable TFT assemblies are being showcased at IBC Disposables for Biopharmaceutical Manufacturing conference California
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Single Domain Antibody
Dr. Marco Pirisinu graduated from the University of Sassari, Italy, with a degree in Biomedical Sciences focusing on the novel design and application of cell penetrating peptide targeting mitochondria. He has more than 10 years of research experience working with academic institutions and biotechnology companies. His primary research interest are nanomedicine, targeted therapy and drug delivery systems. Dr. Pirisinu is first author and corresponding author of peer reviewed articles and Guest Editor forSCI-indexed journals. He is currently Senior Scientist at City University of Hong Kong and Head of Innovative Product Development at Jotbody (HK) Limited.
Dr. Likun Wei obtained his BEng from Tianjin University of Technology, majoring in computer science and MSA from Shanghai Ocean University, majoring in agriculture.He completed his PhD in Biomedical Sciences at City University of Hong Kong in 2021. His PhD work demonstrated a small shark model for affordable high affinity sdAb production.He has co-authored 12 publications in SCI-indexed journals including Nature Communications, Bioresource Technology, Journal of Extracellular Vesicles, Iscience, The Journal of Immunology, and Frontiers in Bioengineering and Biotechnology. Dr. Likun Wei is currently R&D Lead at Jotbody (HK) Limited.
3D Printing Revolutionising Nanotechnology
Mansi Athalye is Assistant Professor in Department of Pharmaceutics at L. M. College of Pharmacy, India with approx. 10 years of teaching and research experience. She has published 12 papers in international and national journals and has presented 22 papers in various conferences as author and co-author with 1 Indian Patent granted in 2018.
Sagar Popat is research student pursuing M. Pharmacy in Pharmaceutics at L. M. College of Pharmacy. He has worked on the topic ‘Cataract of goat eye lens by Invitro and Ex-vivo method’. He has published 1 research article and has won 1st prize in oral presentation at national level conference.
The Role of Artificial Intelligence in Advancing Pharmacovigilance Systems
Rahul Jaiswal is an Assistant Professor at Hygia College of Pharmacy, Lucknow, and a Research Scholar at Integral University, Lucknow. He has been associated with CSIR-CDRI, Lucknow, and has published several articles. His expertise includes molecular techniques, histopathology, and innovative pharmaceutical research, with contributions to national and international conferences.
Nano-Carrier based Smart Drug Delivery Systems
Sidharth Mehta, Researcher in Market Research domain at Prescient Healthcare Group, India. He is a Master’s in Pharmacy (Pharmaceutics) by qualification did his postgraduation from GJUS&T, Hisar, India. His research interests are mainly in the field of nanotechnology. In 2021, he spent a period at University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh (India) with an UGC-NRC project on “Development and Evaluation of Solid Lipid Nanoparticles as Drug Carrier for Topical Delivery of Leflunomide”. He has published several papers in international peer reviewed journals. He had done in-plant training in two pharmaceutical companies and improved his research skill as per industry standards. He worked hard on both his academic and practical skills, as a result of that he qualified national level pharmacy graduate test (GPAT) thrice and NIPER with good rank.
Nikita Yadav, she believes that you can achieve anything at any age. She is a Master’s in Pharmacy (Pharmaceutics) by qualification did her postgraduation from GJUS&T, Hisar, India. Her research interests are mainly in the field of nano- and micro-technology with the use of essentials and natural ingredients. She had many recent experiences like a course in Elsevier[Certified peer reviewer Course], in Good Clinical Practice by NIDA Clinical trials networkandin Regulatory affairs by Udemy.Also, she joined an NGO i.e., Aashman Foundation, which mainly work unconditionally on women empowerment, single income families and underprivileged children through relevant healthcare, innovative education, and environmental based livelihood programs. She also qualified national level pharmacy graduate test (GPAT) in 2020.
The Value in Decolonising Drug Discovery
Jesse Grey Eagle (Oglala Lakota) is the founder of Indigenous Futures OS and a governance designer for Tribal nations. He works at the nexus of ethical data, AI sovereignty, and long-view institutional systems, advocating for partnership architectures that move beyond extraction.
Sabah Ul-Hasan is a Ph.D. scientist with over 15 years of practice in the life sciences. An Indian-Pakistani American based in Albuquerque (New Mexico), Dr. Ul-Hasan centers on ethical data practices that bridge science with community-based knowledge systems.
press releasesRead more...
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
Roche SIX RO ROP OTCQX RHHBY announced today the grand opening of the Roche Genentech Innovation Center Boston expanding Roche and Genentechs US research presence in one
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
Ultragenyx Pharmaceutical Inc NASDAQ RARE today announced that the US Food and Drug Administration FDA granted standard full approval of FAYUVI rebisufligene etisparvovechopf
Tenthpin Launches AI, IoMT-based Centre for Life Sciences Innovation Hub in Bengaluru
Switzerland based Tenthpin Management Consultants a global leader in management and technology consulting for Life Sciences companies has announced the launch of Innovation Hub in Bengaluru
Novo and Anthropic will collaborate to advance drug discovery with Claude
Novo Nordisk and Anthropic today announced a collaboration that will help Novo accelerate the development of new medicines and advance AIdriven software development
Leqembi® Pen subcutaneous formulation approved in Japan
BioArctic AB publs Nasdaq Stockholm BIOA B partner Eisai announced today that the subcutaneous autoinjector formulation of Leqembi known as Leqembi Pen in Japan has been approved as a new route of administration for the treatment of early Alzheimers disease
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
Twist Bioscience Corporation NASDAQ TWST a midcap growth and value biotech company today announced an agreement with Lilly TuneLab a collaborative AIML drug discovery platform created by Eli Lilly and Company
EventsRead more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality Summit
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWSRead more...
Dualitas Therapeutics and Roche Partner to Discover Bispecific Antibodies for I&I Diseases
Dualitas Therapeutics has announced a research collaboration and licence agreement with Roche to discover and develop novel bispecific antibody BsAb therapies for immunology and inflammation II diseases
Eisai and Biogen Receive Approval for LEQEMBI Pen for Early Alzheimer’s Disease
Eisai and Biogen have received approval in Japan for LEQEMBI Pen a subcutaneous SC formulation of lecanemab for the treatment of early Alzheimers disease AD
QurCan Therapeutics Enters into Collaboration with Lilly Advance Nucleic Acid Therapies for Nervous System Diseases
QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop nucleic acid therapies for diseases affecting the central nervous system CNS and peripheral nervous system PNS
BostonGene Expands Collaboration with Dana-Farber Cancer Institute for Breast Cancer Research
BostonGene has expanded its scientific collaboration with DanaFarber Cancer Institute to study the biological mechanisms involved in breast cancers associated with BRCA and BRCA mutations
Telix Receives Approval for Pixclara for Brain Cancer Imaging
Telix Pharmaceuticals has received approval from the US Food and Drug Administration FDA for Pixclara floretyrosine F or FFET a radioactive diagnostic drug used with positron emission tomography PET to image gliomas a type of brain cancer
Evonik Expands Biotechnology Manufacturing Capacity in Slovakia
Evonik has started construction of a biotechnology expansion at its Fermas site in Slovensk upa Slovakia